Moderate Elevation of Homocysteine Induces Endothelial Dysfunction through Adaptive UPR Activation and Metabolic Rewiring
- PMID: 38334606
- PMCID: PMC10854856
- DOI: 10.3390/cells13030214
Moderate Elevation of Homocysteine Induces Endothelial Dysfunction through Adaptive UPR Activation and Metabolic Rewiring
Abstract
Elevation of the intermediate amino acid metabolite Homocysteine (Hcy) causes Hyperhomocysteinemia (HHcy), a metabolic disorder frequently associated with mutations in the methionine-cysteine metabolic cycle as well as with nutritional deficiency and aging. The previous literature suggests that HHcy is a strong risk factor for cardiovascular diseases. Severe HHcy is well-established to correlate with vascular pathologies primarily via endothelial cell death. Though moderate HHcy is more prevalent and associated with an increased risk of cardiovascular abnormalities in later part of life, its precise role in endothelial physiology is largely unknown. In this study, we report that moderate elevation of Hcy causes endothelial dysfunction through impairment of their migration and proliferation. We established that unlike severe elevation of Hcy, moderate HHcy is not associated with suppression of endothelial VEGF/VEGFR transcripts and ROS induction. We further showed that moderate HHcy induces a sub-lethal ER stress that causes defective endothelial migration through abnormal actin cytoskeletal remodeling. We also found that sub-lethal increase in Hcy causes endothelial proliferation defect by suppressing mitochondrial respiration and concomitantly increases glycolysis to compensate the consequential ATP loss and maintain overall energy homeostasis. Finally, analyzing a previously published microarray dataset, we confirmed that these hallmarks of moderate HHcy are conserved in adult endothelial cells as well. Thus, we identified adaptive UPR and metabolic rewiring as two key mechanistic signatures in moderate HHcy-associated endothelial dysfunction. As HHcy is clinically associated with enhanced vascular inflammation and hypercoagulability, identifying these mechanistic pathways may serve as future targets to regulate endothelial function and health.
Keywords: ER stress; TCA cycle; actin cytoskeleton; angiogenesis; endothelial cell; glycolysis; homocysteine; mitochondria; zebrafish.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10854856/bin/cells-13-00214-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10854856/bin/cells-13-00214-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10854856/bin/cells-13-00214-g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10854856/bin/cells-13-00214-g004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10854856/bin/cells-13-00214-g005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10854856/bin/cells-13-00214-g006.gif)
![Figure 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10854856/bin/cells-13-00214-g007.gif)
![Figure 8](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10854856/bin/cells-13-00214-g008.gif)
Similar articles
-
The Contribution of Homocysteine Metabolism Disruption to Endothelial Dysfunction: State-of-the-Art.Int J Mol Sci. 2019 Feb 17;20(4):867. doi: 10.3390/ijms20040867. Int J Mol Sci. 2019. PMID: 30781581 Free PMC article. Review.
-
Coronary Microvascular and Cardiac Dysfunction Due to Homocysteine Pathometabolism; A Complex Therapeutic Design.Curr Pharm Des. 2018;24(25):2911-2920. doi: 10.2174/1381612824666180625125450. Curr Pharm Des. 2018. PMID: 29938610 Review.
-
Homocysteine causes vascular endothelial dysfunction by disrupting endoplasmic reticulum redox homeostasis.Redox Biol. 2019 Jan;20:46-59. doi: 10.1016/j.redox.2018.09.021. Epub 2018 Sep 26. Redox Biol. 2019. PMID: 30292945 Free PMC article.
-
Homocysteine facilitates LOX-1 activation and endothelial death through the PKCβ and SIRT1/HSF1 mechanism: relevance to human hyperhomocysteinaemia.Clin Sci (Lond). 2015 Sep;129(6):477-87. doi: 10.1042/CS20150127. Epub 2015 May 18. Clin Sci (Lond). 2015. PMID: 25982096
-
Molecular processes mediating hyperhomocysteinemia-induced metabolic reprogramming, redox regulation and growth inhibition in endothelial cells.Redox Biol. 2021 Sep;45:102018. doi: 10.1016/j.redox.2021.102018. Epub 2021 May 24. Redox Biol. 2021. PMID: 34140262 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials